About
Technology
Issues
FAQ
Links
Official Page
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.